Feasibility of using an oleate-rich diet to reduce the susceptibility of low-density lipoprotein to oxidative modification in humans

American Journal of Clinical Nutrition

Volumn 54, Issue 4, 1991, Pages 701-706

  Reaven, Peter ^a   Parthasarathy, Sampath ^a   Grasse, Barbara J ^a   Miller, Elizabeth ^a   Almazan, Felicidad ^a   Mattson, Fred H ^a   Khoo, John C ^a   Steinberg, Daniel ^a   Witztum, Joseph L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Conjugated dienes; Macrophages

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; MACROPHAGE; MALE; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL;

ADULT; BODY WEIGHT; CHOLESTEROL; DIET RECORDS; DIETARY FATS, UNSATURATED; FATTY ACIDS; HELIANTHUS; HUMAN; LINOLEIC ACID; LINOLEIC ACIDS; LIPID PEROXIDATION; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL; LIPOPROTEINS, LDL CHOLESTEROL; OLEIC ACIDS; OXIDATION-REDUCTION; PATIENT COMPLIANCE; PLANT OILS; RANDOM ALLOCATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026040120     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/54.4.701     Document Type: Article

References (27)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
2. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 1988;241:215-8.
3. Palinski W, Rosenfeld ME, Ylä-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86:1372-6.
4. Ylä-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-95.
5. Boyd HC, Gown AM, Wolfbauer G, Chait A. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol 1989;135:815-25.
6. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986;77:641-4.
7. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc Natl Acad Sci USA 1987;84:7725-9.
8. Kita T, Nagano Y, Yokode M, et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 1987;84:5928-31.
9. Steinbrecher UP. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 1987;262:3603-8.
10. Parthasarathy S, Fong LG, Otero D, Steinberg D. Recognition of solubilized apoproteins from delipidated, oxidized low density lipoprotein (LDL) by the acetyl-LDL receptor. Proc Natl Acad Sci USA 1987;84:537-40.
11. Sparrow CP, Parthasarathy S, Steinberg D. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem 1989;264:2599-604.
12. The National Diet-Heart Study. American Heart Association Monograph No. 18. New York: American Heart Association, 1968.
13. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990;31:1149-72.
14. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985;26:194-202.
15. Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986;314: 745-8.
16. Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA 1990;87:3894-8.
17. Mattson FH, Pearson J, Contez S. Liquid formula diet for human metabolic studies. Am J Clin Nutr 1982;36:1087-8.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measured with the folin phenol reagent. J Biol Chem 1951;193:265-75.
19. Salacinski PRP, McLean C, Sykes JEC, Clement-Jones W, Lowry PJ. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent. Anal Biochem 1982;117:136-46.
20. Kaplan LA, Miller JA, Stein EA. Simultaneous measurement of serum retinal, tocopherols, carotenes, and carotenoids by high performance liquid chromatography. J Clin Lab Anal 1987;1:147-52.
21. Schudel P, Mayer H, Islen O. Tocopherols, II Chemistry. In: Sebrell WH Jr, Harris RS, eds. Vitamins: chemistry, physiology, pathology, methods. Vol 5. 2nd ed. New York: Academic Press, 1967:168-218.
22. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
23. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
24. Hays WL. Statistics. New York: Holt, Rinehart, and Winston, Inc, 1988.
25. Gutteridge JMC. Free-radical damage to lipids, amino acids, carbohydrates and nucleic acids determined by thiobarbituric acid reactivity. Int J Biochem 1982;14:649-53.
26. Parthasarathy S, Barnett J, Fong L. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990;1044:275-83.
27. Esterbauer H, Retteneder M, Striegle G, et al. Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat Sci Technol 1989;91:316-24.